Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Zhang J, Li J, Zhu C, Song Y, Xia F, Ma X

Drug Design, Development and Therapy 2017, 11:3235-3244

Published Date: 15 November 2017